Form 4: Neuronetics CEO Sells Shares for Tax Obligations

Neuronetics, Inc. President and CEO, Keith J. Sullivan, sold 40,976 shares of common stock to cover tax withholding obligations related to a restricted stock unit award.

Summary

• Keith J. Sullivan, President and CEO, and a Director of Neuronetics, Inc. (STIM), reported a transaction.
• On February 10, 2026, Sullivan sold 40,976 shares of Neuronetics Common Stock.
• The shares were sold at a weighted average price of $1.55 per share, with prices ranging from $1.45 to $1.60.
• This sale was non-discretionary and solely to satisfy tax withholding obligations upon the vesting of a restricted stock unit award.
• Following this transaction, Sullivan beneficially owns 1,567,012 shares of Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine, non-discretionary transaction for tax purposes, not indicative of a change in sentiment or operational performance.

Future Outlook

No future outlook or guidance is provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that insider sales for tax withholding purposes are a common occurrence for executives receiving equity compensation and typically do not signal a change in management's outlook on the company's prospects or broader industry trends.

Comparison to Industry Standards

• StockSavvy.ai finds that sales to cover tax obligations upon RSU vesting are standard practice across industries for executives receiving equity compensation.
• This transaction aligns with typical corporate governance and compensation structures, similar to practices observed at companies like Medtronic or Boston Scientific for their executives' equity awards.

Stakeholder Impact

• Minimal direct impact on shareholders as this is a routine, non-discretionary sale for tax purposes, not a discretionary sale indicating a lack of confidence.
• No direct impact on employees, customers, suppliers, or creditors mentioned.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of shares by the CEO to cover tax obligations related to a restricted stock unit award. Such transactions are common and do not typically reflect a change in the executive's confidence in the company or its future prospects. Therefore, it provides no new fundamental information to warrant a change in investment recommendation, suggesting a 'hold' position is appropriate based solely on this filing.

Keywords

Neuronetics, STIM, Form 4, Insider Trading, Stock Sale, CEO, Restricted Stock Units, Tax Withholding, Beneficial Ownership